UPMC Physicians and Researchers to Present at the 2019 ASTRO Meeting in Chicago
September 5, 2019
UPMC Hillman Cancer Center and University of Pittsburgh physicians and researchers will be well-represented at the 2019 American Society for Therapeutic Radiation and Oncology (ASTRO) Annual Meeting in Chicago from Sept. 15 – 18. The 2019 ASTRO Annual Meeting will focus on innovation, collaboration, and transformation in the field of radiation and oncology. Faculty research will be featured in oral presentations, panel discussions, and poster sessions, highlighting their work in advancing cancer care and improving patient outcomes.
Saturday, Sept. 14
Clinical Cases in Gyn/Onc – 1:15 – 2:30 p.m.
Sushil Beriwal, MD
Sunday, Sept. 15
Poster Session, 1:15 – 2:30 p.m.
SU_25_3171 - Metabolic Risk Factors for the Development of Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer (NSCLC)
Nick Iarrobino, BS
SU_39_3645 - Early Clinical Experience with Varian Halcyon V2 Linear Accelerator: Dual-Isocenter IMRT Planning and Delivery with Portal Dosimetry for Gynecological Cancer Treatments
Hayeon Kim, PhD
SU_6_2060 - Is Multifocal Regression a Risk Factor for Ipsilateral Breast Tumor Recurrence in the Modern Era After Neoadjuvant Chemotherapy and Breast Conservation Therapy?
Diane Ling, MD
Monday, Sept. 16
Poster Session, 10:45 a.m. – noon
MO_15_2281 - Recursive Partitioning Analysis of Patients with Spine Metastases Treated with Stereotactic Body Radiotherapy
Joshua Rodriguez-Lopez, MD
67 - Consolidation Radiotherapy Following PET Complete Response in Early-Stage Hodgkin's Lymphoma: A Meta-analysis
John Austin Vargo, MD
Panel Discussion, 11:02 – 11:14 a.m.
Challenging Case from Dr. Ferris (Head & Neck Surgery)
Robert L. Ferris, MD, PhD
Tuesday, Sept. 17
Breakfast II – 6:45 – 8 a.m.
ASTRO/NCI Diversity Symposium: Pathways for Recruiting and Retaining Women and Under-represented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce
Moderator: Joel Greenberger, MD
Poster Session, 1 – 2:15 p.m.
TU_26_3521 - Mitigation of Irradiation-Induced Damage Using a Three Drug Regiment
Michael Epperly, PhD
TU_40_3789 - Feasibility Study of a New Ring-Gantry Linac for Single Vertebral Segment SBRT
Fang Li, MD
Poster Session, 2:45 – 4 p.m.
TU_19_2545 - Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Cancer: A Single-Institution Retrospective Review
Nick Iarrobino, BS
TU_33_2688 - The Impact of Clinical Pathways on Adoption of Hypofractionated External Beam Radiation in Patients with Low- or Intermediate-Risk Prostate Cancer
Ankur Patel, MD
TU_33_2689 - Impact of Fluciclovine PET/CT on Management of Patients with Biochemically Recurrent Prostate Cancer
Ankur Patel, MD
TU_44_2808 - Adjuvant Bone-Marrow Sparing IMRT in Endometrial Cancer Patients Treated with Sequential Chemotherapy- Does it Help with Completion Rate?
Andrew Keller, MD
TU_46_2830 - Dose-Escalated Intensity Modulated Radiation Therapy in Patients with Locally Advanced Vulvar Cancer- Does It Increase Response Rate?
Adam Richman, MD
TU_9_2446 - Retrocrural Lymph Node Positivity on PET/CT Staging in Esophageal and Gastroesophageal Junction Cancer: Implications for Radiotherapy Clinical Target Volume Design
Phillip Pifer, MD, PhD
Wednesday, Sept. 18
Oral Presentation, 8 – 8:10 a.m.
R-BEL Mitigates Total Body Irradiation By Inhibiting iPLA2? Which Prevents Lipid Mediator Generation in the Ileum
Joel Greenberger, MD
Oral Presentation, 11:15 a.m. – 12:30 p.m.
SS 34 - Head and Neck 3 - Breakthroughs in Head & Neck Cancer
Heath Skinner, MD, PhD
Oral Presentation, 11:40 – 11:45 a.m.
1242 - Regional Control and Dose-Response for Chemoradiotherapy in Locally-Advanced Endometrial Cancer
Uzoma Iheagwara, MD, PhD
Additionally, Robert L. Ferris, MD, Director, UPMC Hillman Cancer Center, along with Joel Greenberger, MD, FACR, FACRO, FASTRO, and Sushil Beriwal, MD, MBA will host a cocktail reception on Sunday, Sept. 15 from 6:00 to 8:00 p.m. at Marriott Marquis (Level 33) Chicago.
For more information and to RSVP for the event, please click here